News: Isis Pharmaceuticals Inc (ISIS.OQ)

ISIS.OQ on NASDAQ Stock Exchange Global Select Market

28.88USD
11:18am EDT
Price Change (% chg)

$-0.41 (-1.40%)
Prev Close
$29.29
Open
$29.08
Day's High
$29.18
Day's Low
$28.73
Volume
69,515
Avg. Vol
507,698
52-wk High
$34.30
52-wk Low
$7.55

Search Stocks
Select another date:

Tue, Jul 30 2013

Isis eyes nationwide mobile payments launch this year

NEW YORK - Isis, a venture of three of the top U.S. mobile providers, said on Tuesday it would expand its much-delayed mobile payments service nationwide later in 2013 after it tested the concept with consumers in two markets.

Isis Pharma drug reduces blood fat by 64 pct in mid-stage study

- Isis Pharmaceuticals Inc said its experimental drug reduced the level of triglycerides, a type of fat in the blood that increases the risk of heart diseases, by up to 64 percent in a mid-stage trial.

Isis Pharma drug reduces blood fat by 64 pct in mid-stage study

July 22 - Isis Pharmaceuticals Inc said its experimental drug reduced the level of triglycerides, a type of fat in the blood that increases the risk of heart diseases, by up to 64 percent in a mid-stage trial.

Isis shares jump after experimental drug cuts blood fat

- Shares of Isis Pharmaceuticals Inc rose as much as 24 percent after the drugmaker said its experimental drug reduced triglycerides, a type of fat, in blood and increased the level of "good" cholesterol.

Roche to use Isis's technology to develop brain disorder drug

- Isis Pharmaceuticals Inc said it will form an alliance with Swiss drugmaker Roche Holding AG to develop treatments for Huntington's disease, a genetic brain disorder, based on the U.S. company's technology.

Roche to use Isis's technology to develop brain disorder drug

April 8 - Isis Pharmaceuticals Inc said it will form an alliance with Swiss drugmaker Roche Holding AG to develop treatments for Huntington's disease, a genetic brain disorder, based on the U.S. company's technology.

Select another date:
Search Stocks